Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia--targeting of disease heterogeneity through direct and indirect antileukemic effects

Leuk Res. 2011 Sep;35(9):1156-8. doi: 10.1016/j.leukres.2011.06.005. Epub 2011 Jul 30.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Benzoquinones / administration & dosage*
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • Histone Deacetylase Inhibitors / administration & dosage*
  • Humans
  • Lactams, Macrocyclic / administration & dosage*
  • Leukemia, Myeloid, Acute / drug therapy*

Substances

  • Benzoquinones
  • HSP90 Heat-Shock Proteins
  • Histone Deacetylase Inhibitors
  • Lactams, Macrocyclic
  • tanespimycin